UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 281

Sortiert nach

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

Leukemia, 2019-07, Vol.33 (7), p.1713-1722

2019

Volltextzugriff (PDF)

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

Leukemia, 2016-02, Vol.30 (2), p.423-430

2016

Volltextzugriff (PDF)

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

Leukemia, 2012-11, Vol.26 (11), p.2398-2405

2012

Volltextzugriff (PDF)

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma

Leukemia, 2017-03, Vol.31 (3), p.637-644

2017

Volltextzugriff (PDF)

VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma

Leukemia, 2008-07, Vol.22 (7), p.1419-1427

2008

Volltextzugriff (PDF)

Clinical feasibility of TBI with helical tomotherapy

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.929-935

2011

Volltextzugriff (PDF)

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

Bone marrow transplantation (Basingstoke), 2004-04, Vol.33 (8), p.823-828

2004

Volltextzugriff (PDF)

Phase II study of pomalidomide in high-risk relapsed and refractory multiple myeloma

Leukemia, 2014-12, Vol.28 (12), p.2413-2415

2014

Volltextzugriff (PDF)

G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.303-304

2013

Volltextzugriff (PDF)

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma

Leukemia, 2015-08, Vol.29 (8), p.1713-1720

2015

Volltextzugriff (PDF)

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

Bone marrow transplantation (Basingstoke), 2001-11, Vol.28 (9), p.873-878

2001

Volltextzugriff (PDF)

Inhibiting MEK in MAPK pathway-activated myeloma

Leukemia, 2016-04, Vol.30 (4), p.976-980

2016

Volltextzugriff (PDF)

Making progress in treating multiple myeloma with total therapies: issue of complete remission and more

Leukemia, 2008-08, Vol.22 (8), p.1633-1636

2008

Volltextzugriff (PDF)

Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib

Blood cancer journal (New York), 2015-01, Vol.5 (1), p.e272-e272

2015

Volltextzugriff (PDF)

Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma

Leukemia, 2015-05, Vol.29 (5), p.1195-1201

2015

Volltextzugriff (PDF)

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

Leukemia, 2014-12, Vol.28 (12), p.2410-2413

2014

Volltextzugriff (PDF)

P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1030-1031

2022

Volltextzugriff (PDF)

Suppression of abnormal karyotype predicts superior survival in multiple myeloma

Leukemia, 2008-04, Vol.22 (4), p.850-855

2008

Volltextzugriff (PDF)

Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2006-02, Vol.37 (4), p.403-409

2006

Volltextzugriff (PDF)

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

Blood cancer journal (New York), 2017-02, Vol.7 (2), p.e535-e535

2017

Volltextzugriff (PDF)

Transplantation as salvage therapy for high-risk patients with myeloma in relapse

Bone marrow transplantation (Basingstoke), 2002-12, Vol.30 (12), p.873-878

2002

Volltextzugriff (PDF)

Human γδ+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response

Bone marrow transplantation (Basingstoke), 2001-03, Vol.27 (6), p.601-606

2001

Volltextzugriff (PDF)

High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 1999-10, Vol.24 (8), p.879-883

1999

Volltextzugriff (PDF)

P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB‐LENALIDOMIDE‐DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE (THE INSURE STUDY)

HemaSphere, 2022-06, Vol.6 (Suppl), p.815-816

2022

Volltextzugriff (PDF)

Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation

Bone marrow transplantation (Basingstoke), 2006-03, Vol.37 (5), p.511-515

2006

Volltextzugriff (PDF)

1 – 25 von 281

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(254)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(145)
Life Sciences & Biomedicine
(124)
Humans
(121)
Biological And Medical Sciences
(73)
Hematology
(72)
Medical Sciences
(68)
Male
(59)
Female
(55)
Oncology
(54)
Middle Aged
(47)
Adult
(43)
Aged
(29)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(29)
Multiple Myeloma
(29)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(29)
Immunology
(28)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(27)
Transplantation
(24)
Prognosis
(23)
Adolescent
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bone Marrow Transplantation
(27)
Journal Of Clinical Oncology
(27)
Blood
(21)
Leukemia
(16)
British Journal Of Haematology
(15)
Neophilologus
(13)
Amsterdamer Beiträge Zur Älteren Germanistik
(10)
Blood Cancer Journal
(7)
Cytotherapy
(5)
Experimental Hematology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma

VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma

Clinical feasibility of TBI with helical tomotherapy

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

Phase II study of pomalidomide in high-risk relapsed and refractory multiple myeloma

G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

Inhibiting MEK in MAPK pathway-activated myeloma

Making progress in treating multiple myeloma with total therapies: issue of complete remission and more

Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib

Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE

Suppression of abnormal karyotype predicts superior survival in multiple myeloma

Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

Transplantation as salvage therapy for high-risk patients with myeloma in relapse

Human γδ+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response

High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients

P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB‐LENALIDOMIDE‐DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE (THE INSURE STUDY)

Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation

Aktive Filter

Suchergebnisse filtern